carmot glp-1 Therapeutics starts phase 2 trial for CT-868, a GLP-1/GIP agonist, to treat Type 1 Diabetes How GLP-1 Receptor Agonists Evolved

Kratom has been used for centuries for various conditions

Delaying the aging process can help prevent, slow down, and alleviate the severity of these various conditions, enhancing overall health and well-being

Robin Zon called the findings a promising hypothesis for #cancerprevention in people with obesity

How many people take GLP-1 medications

Mingo is a GLP-1 tracker app for Ozempic, Mounjaro and Wegovy

Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron